Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 81

1.

Computational evaluation of new homologous down regulators of Translationally Controlled Tumor Protein (TCTP) targeted for tumor reversion.

Nayarisseri A, Yadav M, Wishard R.

Interdiscip Sci. 2013 Dec;5(4):274-9. doi: 10.1007/s12539-013-0183-8.

PMID:
24402820
2.
3.

Translationally controlled tumor protein is a target of tumor reversion.

Tuynder M, Fiucci G, Prieur S, Lespagnol A, GĂ©ant A, Beaucourt S, Duflaut D, Besse S, Susini L, Cavarelli J, Moras D, Amson R, Telerman A.

Proc Natl Acad Sci U S A. 2004 Oct 26;101(43):15364-9.

4.

Biological models and genes of tumor reversion: cellular reprogramming through tpt1/TCTP and SIAH-1.

Tuynder M, Susini L, Prieur S, Besse S, Fiucci G, Amson R, Telerman A.

Proc Natl Acad Sci U S A. 2002 Nov 12;99(23):14976-81.

5.

Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells.

Kadioglu O, Efferth T.

Invest New Drugs. 2016 Aug;34(4):515-21. doi: 10.1007/s10637-016-0339-6.

PMID:
26972431
6.

Growth-factor dependent expression of the translationally controlled tumour protein TCTP is regulated through the PI3-K/Akt/mTORC1 signalling pathway.

Bommer UA, Iadevaia V, Chen J, Knoch B, Engel M, Proud CG.

Cell Signal. 2015 Aug;27(8):1557-68. doi: 10.1016/j.cellsig.2015.04.011.

PMID:
25936523
7.
8.

Translationally controlled tumor protein is a novel biological target for neurofibromatosis type 1-associated tumors.

Kobayashi D, Hirayama M, Komohara Y, Mizuguchi S, Wilson Morifuji M, Ihn H, Takeya M, Kuramochi A, Araki N.

J Biol Chem. 2014 Sep 19;289(38):26314-26. doi: 10.1074/jbc.M114.568253.

9.

Bioinformatic analysis for structure and function of TCTP from Spirometra mansoni.

Lu YJ, Lu G, Shi DZ, Li LH, Zhong SF.

Asian Pac J Trop Med. 2013 Sep;6(9):709-12. doi: 10.1016/S1995-7645(13)60123-6.

10.

Lessons from tumor reversion for cancer treatment.

Amson R, Karp JE, Telerman A.

Curr Opin Oncol. 2013 Jan;25(1):59-65. doi: 10.1097/CCO.0b013e32835b7d21. Review.

PMID:
23165143
11.

Messenger RNA expression of translationally controlled tumor protein (TCTP) in liver regeneration and cancer.

Zhu WL, Cheng HX, Han N, Liu DL, Zhu WX, Fan BL, Duan FL.

Anticancer Res. 2008 May-Jun;28(3A):1575-80.

12.

Role of translationally controlled tumor protein in cancer progression.

Chan TH, Chen L, Guan XY.

Biochem Res Int. 2012;2012:369384. doi: 10.1155/2012/369384.

13.

Characterization of the Translationally Controlled Tumor Protein (TCTP) Interactome Reveals Novel Binding Partners in Human Cancer Cells.

Li S, Chen M, Xiong Q, Zhang J, Cui Z, Ge F.

J Proteome Res. 2016 Oct 7;15(10):3741-3751.

PMID:
27607350
14.

Immunohistochemical localization of translationally controlled tumor protein in the mouse digestive system.

Sheverdin V, Jung J, Lee K.

J Anat. 2013 Sep;223(3):278-88. doi: 10.1111/joa.12077.

15.

Expression and clinical role of TCTP in epithelial ovarian cancer.

Chen C, Deng Y, Hua M, Xi Q, Liu R, Yang S, Liu J, Zhong J, Tang M, Lu S, Zhang Z, Min X, Tang C, Wang Y.

J Mol Histol. 2015 Apr;46(2):145-56. doi: 10.1007/s10735-014-9607-y.

PMID:
25564355
16.

Translationally controlled tumor protein acts as a guanine nucleotide dissociation inhibitor on the translation elongation factor eEF1A.

Cans C, Passer BJ, Shalak V, Nancy-Portebois V, Crible V, Amzallag N, Allanic D, Tufino R, Argentini M, Moras D, Fiucci G, Goud B, Mirande M, Amson R, Telerman A.

Proc Natl Acad Sci U S A. 2003 Nov 25;100(24):13892-7.

17.

Translationally controlled tumor protein supplemented chitosan modified glass ionomer cement promotes osteoblast proliferation and function.

Sangsuwan J, Wanichpakorn S, Kedjarune-Leggat U.

Mater Sci Eng C Mater Biol Appl. 2015 Sep;54:61-8. doi: 10.1016/j.msec.2015.04.036.

PMID:
26046268
18.

Evolutionarily conserved binding of translationally controlled tumor protein to eukaryotic elongation factor 1B.

Wu H, Gong W, Yao X, Wang J, Perrett S, Feng Y.

J Biol Chem. 2015 Apr 3;290(14):8694-710. doi: 10.1074/jbc.M114.628594.

19.
20.

Preparation and characterization of monoclonal antibody against translationally controlled tumor protein.

Qiang M, Fenfang W, Yan G, Wen S, Maoliang H, Yingsong W, Weiwen X, Ming L.

Hybridoma (Larchmt). 2011 Feb;30(1):81-5. doi: 10.1089/hyb.2010.0075.

PMID:
21466289

Supplemental Content

Support Center